Company News


Company News

B-30P can be used in para treatment for patients with COVID-19

Company News
2020-04-16 17:26
Page view:

      ResPlus®B-ventilator is mainly used for patients with mild to moderate respiratory failure, no indication of emergency intubation, relatively stable vital signs and no taboo of noninvasive ventilation. It is used for early intervention and auxiliary evacuation of respiratory failure

       Nowadays,COVID-19 which causedby the novelcoronavirus outbreaks worldwide.The virus will quickly invadehuman lung cells and cause pne-umonia, which will cause severe lower respirat-ory tract diseases, such as acute lung injurya-nd respiratory distress syndrome. Some criticalpati-entmay even have symptoms such as resp-iratory failure, refractory hypoxemia,shock,mul-tiple organ failure,and coagulopathy.

      For COVID-19,ventilator is one of the most effe-ctive treatments in the absence of specific dru-gs.Under ventilated, the blood oxygen of patie-nt  can be effectively improved and the morta-lity rate can be reduced.


How to avoid nosocomial infections with non-invasive

Filter needs to pay attention to the problem of increased resistance to water overload. The increased resistance needs to be replaced at any time!


B-30P can be used in para treatment for patients with COVID-19.



  1. Small size, color LCD display
  2. Portable and easy to operate
  3. Can be equipped with trolleys 
  4. Can be equipped with independent humidifier
  5. Can be equipped with SPO2 module
  6. Real-time display and monitoring of clinical use data of patients;
  7. Connect to Low-flow oxygen, for air-oxygen mixing;
  8. With VAF (Vital assurance function);
  9. Max.IPAP: 30cmH2O;
  10. Ventilation mode: CPAP, S, ST, T, APCV.


Non-invasive ventilation is mainly applicable to patients with mild to moderate respiratory failure, no evidence of emergency intubation, relatively stable vital signs, and no contraindications to non-invasive ventilation. It is used for early intervention and assisted withdrawal of respiratory failure.


Using environments

1.Early intervention for respiratory failure for patients with COVID-19;

2.After extubating, when the patient is removed from the invasive ventilator and transferred to a non-invasive ventilator.The patient has a certain ability to breathe spontaneously and is in good condition, or applied when transferred to a general ward.


Guidelines for non-invasive ventilation for patients with COVID-19

For mild to moderate patients (PaO2<60mmHg,SpO2<90%,RR>24), non-invasive ventilation can be considered for respiratory support when oxygen therapy is not effective.



ISO 13485, CE0197, ISO14001, ISO 9001


Product name Non-invasive ventilator

Model ResPlus®B-30P

Screen 3.5'' colorful LCD

Respiratory mode CPAPSSTTAPCV

Weight 2.2Kg

Dimension 280mm*200mm*112mm 

       Noise Level<30dBA


       IPAP(cmH2O):4-30cmH2O       EPAP(cmH2O): 4-25cmH2O  

IsensAuto,1-6 level              Esens Auto,1-6 level

Islop1-6 level

InspTime 0.5-4s     Max-InspTime 0.5-4s      Min-InspTime 0.5-4s

BPM 3-40bpm

Humidifier 0-5 level

Auto-On On/Off

Auto-Off On/Off

Auto-air compensation Available

Auto-adjustment altitude Available

VAF settings Available

Target VT 50-2000ml

Ramp 0-60 min

Data storage: TF card